Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| BGLC (BioNexus Gene Lab Corp Common stock) | -33.92% | -10.92% | -64.35% | -23.56% | NA | NA | NA | … | … |
Data as of 06/18/2026, Common starting date is 01/11/2021
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| BGLC (BioNexus Gene Lab Corp Common stock) | 01/11/2021 | 06/18/2026 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | YTD | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | 23.70 | -10.92 | -64.35 | -23.56 | NA | NA | NA | … | … | -33.92 | 41.07 | -47.17 | -44.21 | -55.40 | -3.18 |
| Sharpe Ratio | NA | -0.17 | -0.30 | -0.15 | NA | NA | NA | … | … | -1.07 | 0.20 | -0.28 | -0.12 | -0.42 | -0.01 |
| Standard Deviation(%) | NA | 174.60 | 210.56 | 244.17 | NA | NA | NA | … | … | 71.87 | 191.26 | 178.72 | 403.27 | 134.97 | 271.86 |
| Draw Down(%) | NA | 82.59 | 98.65 | 98.65 | NA | NA | NA | … | … | 52.33 | 66.34 | 85.35 | 97.71 | 67.71 | 57.98 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 06/18/2026, Common starting date is 01/11/2021
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| BGLC (BioNexus Gene Lab Corp Common stock) |
-72.12%
Jan 2023 – Jan 2026 |
-36.67%
Mar 2021 – Mar 2026 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| BGLC (BioNexus Gene Lab Corp Common stock) |
-9.66%
Jul 2022 – Jul 2025 |
-28.01%
May 2021 – May 2026 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart